case report aspiration anesthesia semaglutide 2023 during What happened in medicine this week has real consequences in GLP-1 Agonists and the Risk – Should Wegovy (semaglutide) be stopped

I was skeptical to say the least

The efficacy of the approach is demonstrated with three GLP-1-oligourea hybrids showing prolonged activity in vivo

One problem with this method in general is that the sample, when presented, is a poor reflection of the real changes in odour that have taken place during the time in which it was collected (a similar point has been made to use of static facial images in visual communication: Jack & Schyns, Reference Jack and Schyns2015)

doi: 10.1016/S0140-6736(13)60852-1 23

Mounjaro and Zepbound are FDA-approved finished drugs that are trademarks of their respective owner

The opportunity lies in companies focusing on healthier, nutrient-rich products that GLP-1 users might favor